[Aetiology and treatment of epilepsy in a series of 1,557 patients]
| Autor: | Marta, Torres-Ferrús, Manuel, Toledo, Montserrat, González-Cuevas, Laia, Seró-Ballesteros, Esteban, Santamarina, Miquel, Raspall-Chaure, María, Sueiras-Gil, Roser, Cambrodí-Masip, Silvana, Sarria, José, Álvarez-Sabín, Javier, Salas-Puig |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Intracranial Arteriovenous Malformations Male Hemangioma Cavernous Central Nervous System Adolescent Hospitals University Young Adult Age Distribution Tuberous Sclerosis Meningeal Neoplasms Humans Hypoxia Brain Aged Aged 80 and over Epilepsy Brain Neoplasms Middle Aged Stroke Cross-Sectional Studies Spain Brain Injuries Encephalitis Anticonvulsants Epilepsy Generalized Female Epilepsies Partial |
| Zdroj: | Revista de neurologia. 57(7) |
| ISSN: | 1576-6578 |
| Popis: | The aetiology of epilepsy is an important decisive factor in its treatment and prognosis. Diagnostic and therapeutic advances suggest that the causal distribution, treatment and prognosis of the population with epilepsy may have undergone some modification.To describe the distribution of syndromes, aetiology and pharmacological treatment in patients with epilepsy.We conducted a cross-sectional descriptive study of patients with epilepsy who were treated consecutively in our epilepsy department. Demographic data were collected, together with information about syndromes, aetiology and pharmacological treatment at the time of eligibility. The data were analysed jointly and by age groups.Altogether 1,557 patients were included, 54% of them males. Seventy-three per cent of the sample had focal epilepsy, which was secondary to a structural lesion in 56% of patients. Generalised epilepsies accounted for 20%. Five per cent were unclassifiable. By ages, vascular causation predominated in practically all the groups and its prevalence increased with age. The most commonly used antiepileptic drugs were valproic acid (29%), levetiracetam (27%) and carbamazepine (20%). Seventy per cent of the generalised epilepsies and 57% of the focal ones were on monotherapy treatment.The prevalence by age groups was similar to that reported in developed countries, although a lower prevalence of cryptogenic epilepsies was observed. More than 60% of patients followed monotherapy and valproic acid was the most widely used.Etiologia y tratamiento de la epilepsia en una serie de 1.557 pacientes.Introduccion. La etiologia de la epilepsia es un determinante importante del tratamiento y el pronostico. Los avances diagnosticos y terapeuticos hacen pensar que la distribucion causal, el tratamiento y el pronostico de la poblacion con epilepsia se hayan podido ver modificados. Objetivo. Describir la distribucion sindromica, etiologica y el tratamiento farmacologico en los pacientes con epilepsia. Pacientes y metodos. Estudio descriptivo transversal de pacientes con epilepsia atendidos de manera consecutiva en la consulta de nuestra unidad de epilepsia. Se recogieron datos demograficos, de sindrome, etiologia y tratamiento farmacologico en el momento de la inclusion. Se analizaron los datos de modo conjunto y por grupos de edad. Resultados. Se incluyeron 1.557 pacientes, el 54% varones. El 73% de la muestra tenia una epilepsia focal, que era secundaria a una lesion estructural en el 56%. Las epilepsias generalizadas representaron el 20%. El 5% fue inclasificable. Por edad, la etiologia vascular predominaba en practicamente todos los grupos y su prevalencia aumentaba en relacion con la edad. Los farmacos antiepilepticos mas utilizados fueron acido valproico (29%), levetiracetam (27%) y carbamacepina (20%). El 70% de las epilepsias generalizadas y el 57% de las focales seguian tratamiento en monoterapia. Conclusiones. La prevalencia por grupos de edad fue similar a la descrita en paises desarrollados aunque se observo una menor prevalencia de epilepsias criptogenicas. Mas del 60% de los pacientes seguia monoterapia y el acido valproico fue el mas utilizado. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|